Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-12 · accession 0001396814-24-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-12 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | A - Grant | $0.00 | +54.3K | 110.4K | +97% | $0 | |
| 2024-06-13 | 2024-06-13 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $28.38 | -7,452 | 102.9K | -7% | -$211.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | A | A | 54,300 | $0.00 | 110,364 | D | — | — | (F1) Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. |
| 2 | Common | Common Stock | 2024-06-13 | S | D | 7,452 | $28.38 | 102,912 | D | — | — |